Scarica l'app Stockscreener
2.22
2.63%
-0.06
Precedente Chiudi:
$2.28
Aprire:
$2.28
Volume 24 ore:
94,062
Relative Volume:
0.24
Capitalizzazione di mercato:
$134.47M
Reddito:
-
Utile/perdita netta:
$-64.86M
Rapporto P/E:
-1.9821
EPS:
-1.12
Flusso di cassa netto:
$-55.66M
1 W Prestazione:
-1.33%
1M Prestazione:
+80.49%
6M Prestazione:
+126.53%
1 anno Prestazione:
-7.11%
Intervallo 1D:
$2.17
$2.32
Intervallo di 1 settimana:
$2.01
$2.40
Portata 52W:
$0.8551
$3.36
Acumen Pharmaceuticals Inc Stock (ABOS) Company Profile
Nome
Acumen Pharmaceuticals Inc
Settore
Industria
Telefono
617-344-4190
Indirizzo
1210-1220 WASHINGTON STREET, NEWTON
Confronta ABOS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals Inc
|
2.22 | 141.14M | 0 | -64.86M | -55.66M | -1.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
411.83 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
485.43 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
582.87 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
832.36 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.26 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Acumen Pharmaceuticals Inc Stock (ABOS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-17 | Iniziato | Citigroup | Buy |
| 2024-07-26 | Iniziato | Citigroup | Buy |
| 2023-12-12 | Iniziato | Deutsche Bank | Buy |
| 2023-07-20 | Ripresa | BofA Securities | Buy |
| 2023-05-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-07-15 | Iniziato | BTIG Research | Buy |
| 2022-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2022-01-21 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-07-26 | Iniziato | BofA Securities | Neutral |
| 2021-07-26 | Iniziato | Credit Suisse | Outperform |
| 2021-07-26 | Iniziato | Stifel | Buy |
| 2021-07-26 | Iniziato | UBS | Buy |
Mostra tutto
Acumen Pharmaceuticals Inc Borsa (ABOS) Ultime notizie
Tools to monitor Acumen Pharmaceuticals Inc. recovery probability2025 Major Catalysts & Capital Efficiency Focused Strategies - newser.com
Acumen Pharmaceuticals (NASDAQ:ABOS) Receives “Sell (D-)” Rating from Weiss Ratings - Defense World
When is the best time to exit Acumen Pharmaceuticals Inc.Earnings Miss & AI Forecast Swing Trade Picks - newser.com
Long term hold vs stop loss in Acumen Pharmaceuticals Inc.2025 Earnings Surprises & AI Driven Price Predictions - newser.com
Relative strength of Acumen Pharmaceuticals Inc. in sector analysisJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com
Acumen Pharmaceuticals Inc. stock retracement – recovery analysisTrade Analysis Summary & Weekly Top Performers Watchlists - newser.com
What to do if you’re stuck in Acumen Pharmaceuticals Inc.2025 Price Momentum & Target Return Focused Stock Picks - newser.com
What the charts say about Acumen Pharmaceuticals Inc. todayQuarterly Portfolio Report & Safe Investment Capital Preservation Plans - newser.com
Is Acumen Pharmaceuticals Inc. stock a top pick in earnings season2025 Winners & Losers & Low Risk Investment Opportunities - newser.com
How Acumen Pharmaceuticals Inc. stock reacts to oil prices2025 Retail Activity & Free Real-Time Market Sentiment Alerts - newser.com
Central Nervous System Biomarkers Market Growth & Industry - openPR.com
What analysts say about Acumen Pharmaceuticals Inc stockMomentum Trading Signals & Stay One Step Ahead of Risk Events - earlytimes.in
Institutional scanner results for Acumen Pharmaceuticals Inc.Quarterly Profit Report & Risk Managed Investment Entry Signals - newser.com
Trend analysis for Acumen Pharmaceuticals Inc. this weekWeekly Profit Recap & AI Driven Price Forecasts - newser.com
Published on: 2025-10-05 05:00:14 - newser.com
Will Acumen Pharmaceuticals Inc. stock return to pre crisis levelsJuly 2025 News Drivers & Safe Swing Trade Setup Alerts - newser.com
Is it time to cut losses on Acumen Pharmaceuticals Inc.July 2025 Trends & Verified Momentum Watchlists - newser.com
Promising Penny Stocks To Watch In September 2025 - Yahoo Finance
Analyzing net buyer seller activity in Acumen Pharmaceuticals Inc.July 2025 Setups & AI Powered Market Entry Ideas - newser.com
Is Acumen Pharmaceuticals Inc a good long term investmentHigh Dividend Yield Stocks & Outstanding Capital Tips - earlytimes.in
Acumen Pharmaceuticals, Inc. $ABOS Shares Sold by Goldman Sachs Group Inc. - Defense World
Acumen Pharmaceuticals Inc Azioni (ABOS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Acumen Pharmaceuticals Inc Azioni (ABOS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Zuga Matt | CFO & Chief Business Officer |
Jan 21 '25 |
Sale |
1.60 |
4,364 |
6,986 |
260,646 |
| OConnell Daniel Joseph | Chief Executive Officer |
Jan 21 '25 |
Sale |
1.59 |
12,619 |
20,102 |
667,488 |
| Meisner Derek M | Chief Legal Officer & Corp Sec |
Jan 21 '25 |
Sale |
1.59 |
3,418 |
5,435 |
161,127 |
| Barton Russell | Chief Operating Officer |
Jan 21 '25 |
Sale |
1.61 |
2,914 |
4,692 |
136,117 |
| Siemers Eric | Chief Medical Officer |
Jan 21 '25 |
Sale |
1.59 |
3,219 |
5,118 |
170,298 |
0.82%
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):